Embed Size (px)
Citation preview
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars Miscellaneous
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
Recent evidence-based COVID-19 guidelines (MULTI-REGIONAL)
WHO: Clinical management of SARI when COVID-19 is suspected. GLOBAL
ANZICS: COVID-19 Guidelines – V1.AUSTRALIA NEW ZEALAND
ANZICS: COVID-19 Guidelines – V2.AUSTRALIA NEW ZEALAND
Handbook of Covid-19 Prevention and Treatment (first affiliated Chinese hospital).CHINA
Surviving Sepsis Campaign: Guidelines for COVID-19 management.EUROPE AND USA COMBINED
Saudi Ministry of Health. Use of high flow nasal cannula in respiratory failure in adult patients with COVID-19 respiratory failure.MIDDLE EAST
Physiotherapy care of patients with COVID-19 - A Brazilian experience.BRAZIL
WHO: TECHNICAL SPECIFICATIONS for invasive and non-invasive ventilators for COVID-19.GLOBAL
Society Critical Care Medicine (SCCM) summary video of NHF use in COVID-19 Respiratory Failure.USA
NIH COVID-19 Guidelines.USA
The Internet Book of Critical Care.GLOBAL
Click links for further reading on COVID-19 guidelines...
X
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
Clinical webinars (MULTI-REGIONAL)
EMCrit - Stop Kneejerk intubating.USA• 00:44 Early intubation discussed• 7:20 Aerosolization discussed
Thinking Critical Care – COVID Clinical Discussion with Cameron Kyle-Sidell: NYC ED/ICU Doc in the trenches.USA• 1:10 Local experience of COVID-19 discussed• 12:25 NHF use and “triggers” for intubation
FOAMcast - Emergency Medicine Core Content: The State of Our Current Respiratory Management.USA • 4:30 Aerosols during coughing and
intubation• 7:00 NHF and proning discussed
ER Cast: COVID-19 Inside NYC. Dr Reuben Strayer.USA• 6:20 PPE discussed• 16:20 CPAP pre-oxygenation discussed• 18:10 NHF discussed• 23:10 Pre-oxygenation with NHF
Click links to view further information on COVID-19.
Q&A with University of Chicago Medicine physicians on the frontlines treating COVID-19.USA• 8:35 NIV helmet assemblies described• 9:30 NHF comments and experience• 17:10 CPAP use in COVID-19
Evidence-based recommendations for preventing nosocomial transmission during respiratory care for COVID-19 patients.USA
ATS Webinar: Nicholas Hill: Non-invasive techniques in the COVID-19 Pandemic.USA• 5:00 Summary of existing guidelines• 7:57 Technical differences and
distinctions between NHF and NIV• 9:25 Indications for NIV• 27:00 NHF discussed• 30:10 Aerosol dispersion• 48:00 ROX index
Philips: International Learning from COVID-19 – Webinar Series 3.EUROPE• 7:30 Italian experience with CPAP in
COVID-19 (Dr Annalisa Carlucci)• 19:00 Temple University, USA, experience
with NHF and early analysis of data• 37:00 Dr Nick Hart (London) discusses
intubation strategies, pathophysiology of COVID-19 and oxygen supply
• 1:16:00 Dr Wolfram Windisch (Germany) describes experience
• 1:46:00 Dr Mark Elliot (Chair, UK) discusses CPAP v NHF in COVID-19 survey results
Philips: International Learning from COVID-19 – Webinar Series 4.EUROPE• 1:34:50 Aerosolization and cross infection
discussed
Philips: International Learning from COVID-19 – Webinar Series 2.EUROPE• 31:00 - 1:10:00 Non-invasive
respiratory support strategies discussed
• 1:21:00 Aerosolization discussed (Dr Hui, Hong Kong)
• 1:26:00 Summary from Dr Mark Elliot (Chair, UK)
X
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
Infection risk & uncertainty (MULTI-REGIONAL)
WHO: Infection prevention and control when coronavirus infection is suspected.GLOBAL
WHO: Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations.GLOBAL
Li et al. High-flow aerosol dispersing – versus aerosol generating procedures. AJRCCM.USA
Gaeckle, N. et al. Aerosol generation from the respiratory tract with various modes of oxygen delivery. AJRCCM.USA
Kaur, R. et al. Practical strategies to reduce nosocomial transmission to healthcare professionals providing respiratory care to patients with COVID-19. Critical Care.USA
Whittle, S. et al. Respiratory support for adult patients with COVID-19. JACEP Open.USA
Leung, C. et al. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients. J Hosp Infect.EUROPE
Li, J. et al. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur. Respir. J.USA
Kotoda, M. et al. Assessment of the potential for pathogen dispersal during high-flow nasal therapy. J Hosp Infect.JAPAN
Hui, D. et al. Exhaled air dispersion during high flow nasal cannula therapy versus CPAP via different masks. Eur. Respir. J.HONG KONG
COVID 19: how to minimize the risk of air dispersion during respiratory support.ITALY (Video)
Evidence-based recommendations for preventing nosocomial transmission during respiratory care for COVID-19 patients. ISAM.GLOBAL (Video and slide presentation)
Click links below for further reading on COVID-19 and aerosolization of the virus.
X
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
XArticles, studies, systematic reviews & opinions (MULTI-REGIONAL)
Lalla, U. et al. The utility of HFNC oxygen therapy in the management of respiratory failure secondary to COVID-19 pneumonia. S Afr Med J.SOUTH AFRICA
Vianello, A. et al. Assessment of outcomes and safety of HFNC in AHRF consequent to COVID-19.* ITALY
Zucman, N. et al. Using the ROX index to predict outcome of NHF use during COVID-19 AHRF. Intensive Care Med.EUROPE
Deng, L. et al. Outcome of early versus late HFNC in elderly COVID-19 ARDS patients.GLOBAL
Patel, M. et al. Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxemic respiratory failure. BMJ Open Respiratory Research.* USA
Guy, T. et al. High Flow Nasal Oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU. Eur. Respir. J.* FRANCE
Franco, C. et al. Feasibility and clinical impact of out-of-ICU non-invasive respiratory support in patients with COVID-19-related pneumonia. Eur. Respir. J.* ITALY
SYSTEMATIC REVIEW: NHF for AHRF in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth.GLOBAL
Toronto Centre of Excellence Message to Respiratory Therapists.CANADA
TIME: Why ventilators may not be working as well for COVID-19 patients as doctors hoped. USA
NY Times: New Jersey’s first Coronavirus patient.USA
Hu et al. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study.
CHINA
PAGE
1 OF 2
* publication reports observations on both NHF outcomes as well as staff infection rates.
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
XArticles, studies, systematic reviews & opinions (MULTI-REGIONAL)
NPR: Ventilators are no panacea for critically ill COVID-19 patients.USA
Professor Kim Woo-Ju, Korea University talks about Korea’s approach.KOREA
Gattinoni, L. et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med.ITALY
Raoof, S. et al. How I do it: High flow, non-invasive ventilation and awake (non-intubation) proning in COVID-19 patients with respiratory failure.USA
Duan, J. et al. Use of HFNC and NIV in patients with COVID-19: a multicentre observational study. Am J Emerg Med.*CHINA
Gattinoni, L. et al. COVID-19 pneumonia: ARDS or not? Critical Care.ITALY
NY TImes: What doctors on the front lines wish they’d known a month ago.USA
PAGE
2 OF 2
* publication reports observations on both NHF outcomes as well as staff infection rates.
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
Miscellaneous X F&P Healthcare COVID-19 Resource Center.GLOBAL
Fisher & Paykel Healthcare Optiflow Flow Matters - Vol. 10.GLOBAL
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
USA AND CANADA
ER Cast: COVID-19 – Inside NYC. Dr Reuben Strayer.
Q&A with University of Chicago Medicine physicians on COVID-19.
NY Times: What doctors on the front lines wish they’d known a month ago.
X
NIH COVID-19 Guidelines.USA
Toronto Centre of Excellence Message to Respiratory Therapists.
Whittle, S. et al. Respiratory support for adult patients with COVID-19. JACEP Open.
Li, J. et al. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur. Respir. J.
EMCrit – Stop Kneejerk intubating.
Thinking Critical Care – COVID Clinical Discussion with NYC ED/ICU Doctor.
ATS: Nicholas Hill: Non-invasive techniques in the COVID-19 pandemic.
Click links below for more information on COVID-19...
FOAMcast - The State of Our Current Respiratory Management.
Patel, M. et al. Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxemic respiratory failure. BMJ Open Respiratory Research.
TIME: Why ventilators may not be working as well for COVID-19 patients as doctors hoped.
Society Critical Care Medicine: summary video of NHF use in COVID-19 respiratory failure.USA
Raoof, S. et al. How I do it: High flow, non-invasive ventilation and awake (non-intubation) proning in COVID-19 patients with respiratory failure.
Physiotherapy care of patients with COVID-19. BRAZIL
Li et al. High-flow aerosol dispersing – versus aerosol generating procedures. AJRCCM.
Gaeckle, N. et al. Aerosol generation from the respiratory tract with various modes of oxygen delivery. AJRCCM.
Kaur, R. et al. Practical strategies to reduce nosocomial transmission to healthcare professionals providing respiratory care to patients with COVID-19. Critical Care.
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
ASIA & PACIFIC
Handbook of COVID-19 Prevention and Treatment (first affiliated Chinese hospital).CHINA
Kotoda, M. et al. Assessment of the potential for pathogen dispersal during high-flow nasal therapy. Journal of Hospital Infection.JAPAN
Hui, D. et al. Exhaled air dispersion during high flow nasal cannula therapy versus CPAP via different masks. European Respiratory Journal. HONG KONG
Professor Kim Woo-Ju, Korea University talks about Korea’s approach.KOREA
Click links below for more information on COVID-19... X
ANZICS: COVID-19 Guidelines – V1.AUSTRALIA NEW ZEALAND
ANZICS: COVID-19 Guidelines – V2.AUSTRALIA NEW ZEALAND
Hu et al. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study.
CHINA
Saudi Ministry of Health. Use of high flow nasal cannula in respiratory failure in adult patients with COVID-19 respiratory failure.MIDDLE EAST
Duan, J. et al. Use of HFNC and NIV in patients with COVID-19: a multicentre observational study. Am J Emerg Med.CHINA
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
EUROPE Click links below for more information on COVID-19... X Surviving Sepsis Campaign: Guidelines for COVID-19 management.EUROPE AND USA
Philips: International Learning from COVID-19 – Webinar Series 2.EUROPE
Philips: International Learning from COVID-19 – Webinar Series 3.EUROPE
Philips: International Learning from COVID-19 – Webinar Series 4.EUROPE
Ferioli, M. et al. Protecting healthcare workers from SARS-CoV-2 infection: practical indications. Eur. Respir. J.EUROPE
Leung, C. et al. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients. J. Hosp. Infect.EUROPE
Gattinoni, L. et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med.ITALY
Gattinoni, L. et al. COVID-19 pneumonia: ARDS or not? Critical Care.ITALY
COVID 19: how to minimize the risk of air dispersion during respiratory support.ITALY
Vianello, A. et al. Assessment of outcomes and safety of HFNC in AHRF consequent to COVID-19. ITALY
Zucman, N. et al. Using the ROX index to predict outcome of NHF use during COVID-19 AHRF. Intensive Care Med.EUROPE
Guy, T. et al. High Flow Nasal Oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU. Eur. Respir. J. FRANCE
Franco, C. et al. Feasibility and clinical impact of out-of-ICU non-invasive respiratory support in patients with COBID-19 related pneumonia. Eur. Respir. J. ITALY
Europe
Asia & Pacific
Americas
Links to some of the latest information and resources on Nasal High Flow (NHF) use with COVID-19 patients
ISSUE
3OCTOBER
2020
Global
62112
1 REV
C 2
020-
10 ©
202
0 Fi
sher
& P
ayke
l Hea
lthca
re L
imite
d
Recent evidence- based COVID-19
guidelinesInfection risk & uncertainty
Articles, studies, systematic reviews
& opinionsClinical
webinars
= new for this issue
Miscellaneous
GLOBAL
The Internet Book of Critical Care.
The Internet Book of Critical Care – Covid podcast #5.
WHO: Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations.
Click links below for more information on COVID-19...
Evidence-based recommendations for preventing nosocomial transmission during respiratory care for COVID-19 patients. The International Society for Aerosols in Medicine.Video and slide presentation
WHO: Clinical management of severe acute respiratory infection when COVID-19 is suspected.
WHO: Infection prevention and control when coronavirus infection is suspected.
X
F&P Healthcare COVID-19 Resource Center.
Deng, L. et al. Outcome of early versus late HFNC in elderly COVID-19 ARDS patients.
SYSTEMATIC REVIEW: High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth.
WHO: TECHNICAL SPECIFICATIONS for invasive and non-invasive ventilators for COVID-19.
